(NYSE: PRGO) Perrigo Co's forecast annual revenue growth rate of 2.93% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 9.19%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.
Perrigo Co's revenue in 2024 is $4,655,600,000.On average, 3 Wall Street analysts forecast PRGO's revenue for 2024 to be $630,659,469,376, with the lowest PRGO revenue forecast at $630,386,269,243, and the highest PRGO revenue forecast at $630,914,781,405. On average, 3 Wall Street analysts forecast PRGO's revenue for 2025 to be $663,306,614,241, with the lowest PRGO revenue forecast at $651,398,015,585, and the highest PRGO revenue forecast at $671,068,154,131.
In 2026, PRGO is forecast to generate $686,480,381,874 in revenue, with the lowest revenue forecast at $676,116,122,859 and the highest revenue forecast at $693,693,895,306.